YolTech Therapeutics Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series C

  • Latest Deal Amount
  • $73.4M

  • Investors
  • 24

YolTech Therapeutics General Information

Description

Developer of in vivo gene editing therapies focusing on serious diseases using lipid nanoparticle delivery systems. The company specialises in clinical-stage therapies targeting transthyretin amyloidosis, familial hypercholesterolemia, and primary hyperoxaluria type 1, thereby improving treatment outcomes through scalable, manufacturing, and next-generation gene editing technologies.

Contact Information

Website
www.yoltx.com
Formerly Known As
Yaotang (Shanghai) Biotechnology
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Shanghai R&D Center, 12th Floor, Building 1
  • Number 58 Tanzhu Road, Minhang District
  • Shanghai, 201109
  • China
+86 021
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Nanotechnology, Manufacturing, Life Sciences, Oncology
Corporate Office
  • Shanghai R&D Center, 12th Floor, Building 1
  • Number 58 Tanzhu Road, Minhang District
  • Shanghai, 201109
  • China
+86 021

YolTech Therapeutics Timeline

2023202420252026
Financing Round

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

YolTech Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series C) 28-May-2026 $73.4M Completed Generating Revenue
5. Early Stage VC (Series B) 10-Sep-2025 Completed Generating Revenue
4. Early Stage VC 05-Feb-2024 Completed Generating Revenue
3. Early Stage VC (Series A1) 21-Sep-2023 Completed Generating Revenue
2. Early Stage VC (Series A) 09-Aug-2022 $14.8M $16.4M Completed Generating Revenue
1. Seed Round 27-Oct-2021 $1.55M $1.55M Completed Startup
To view YolTech Therapeutics’s complete valuation and funding history, request access »

YolTech Therapeutics Patents

  • 43

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 24

    Pending

  • Expiring in next 12 mo

YolTech Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026222691-A1 Lipid compounds and lipid nanoparticle compositions Pending 23-Apr-2025
WO-2026214774-A1 Adenosine deaminase, fusion protein, base editor system, and use thereof Pending 11-Apr-2025
WO-2026201207-A1 Lipid compound, lipid nanoparticle composition, and use thereof Pending 25-Mar-2025
WO-2026183772-A1 Lipid compounds and lipid nanoparticle compositions Pending 06-Mar-2025
WO-2026067861-A1 Composition for treating hemoglobinopathy and use thereof Pending 30-Sep-2024
To view YolTech Therapeutics’s complete patent history, request access »

YolTech Therapeutics Investors (24)

Investor Name Investor Type Holding Investor Since Participating Rounds
Shanghai Deyue Investment Growth/Expansion Minority
Shanghai Guotou Pioneer Private Equity Fund Management Fund of Funds Minority
Shanghai Minhang Government Government Minority
CICC Capital PE/Buyout Minority
Core Energy Ventures Infrastructure Minority
You’re viewing 5 of 24 investors. Get the full list »

Ready to get started?

Request a free trial

YolTech Therapeutics FAQs

  • When was YolTech Therapeutics founded?

    YolTech Therapeutics was founded in 2021.

  • Where is YolTech Therapeutics headquartered?

    YolTech Therapeutics is headquartered in Shanghai, China.

  • What industry is YolTech Therapeutics in?

    YolTech Therapeutics’s primary industry is Drug Discovery.

  • Is YolTech Therapeutics a private or public company?

    YolTech Therapeutics is a Private company.

  • What is YolTech Therapeutics’s current revenue?

    The current revenue for YolTech Therapeutics is .

  • How much funding has YolTech Therapeutics raised over time?

    YolTech Therapeutics has raised $145M.

  • Who are YolTech Therapeutics’s investors?

    Shanghai Deyue Investment, Shanghai Guotou Pioneer Private Equity Fund Management, Shanghai Minhang Government, CICC Capital, and Core Energy Ventures are 5 of 24 investors who have invested in YolTech Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process